Loading clinical trials...
Loading clinical trials...
A Multicenter, Evaluator-blinded, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing
Conditions
Interventions
JUVÉDERM® VOLUMA® XC
No-treatment control
Locations
15
United States
Skin Care and Laser Physicians of Beverly Hills /ID# 232967
Los Angeles, California, United States
Steve Yoelin MD Medical Associate Inc /ID# 232956
Newport Beach, California, United States
Steven Fagien MD PA /ID# 232807
Boca Raton, Florida, United States
Bradenton Dermatologist /ID# 232822
Bradenton, Florida, United States
Hevia Cosmetic Dermatology /ID# 232824
Coral Gables, Florida, United States
Skin and Cancer Associates, LLP /ID# 232923
Miami, Florida, United States
Start Date
May 28, 2020
Primary Completion Date
October 17, 2022
Completion Date
October 17, 2022
Last Updated
April 25, 2024
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions